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Abstract
● AIM: To assess the relationship between choroidal 
thickness and renal function in diabetic patients. 
● METHODS: Cross-sectional retrospective clinical study 
of 42 eyes of 21 ocular treatment-naïve diabetic patients. 
Demographic data included: age, sex, type and course 
of diabetes. Ocular data included: severity of diabetic 
retinopathy; retinal thickness at the central macular 
region, as well as choroidal thickness at the central and 
paracentral quadrants, using automatically generated 
maps by swept-source optical coherence tomography; 
presence of cystic macular edema; and ocular axial length 
(AXL). Lab-test parameters included: glycated hemoglobin 
(HbA1c), albuminuria, albumin/creatinine ratio in urine, and 
glomerular filtration rate. 
● RESULTS: A significant negative correlation was mainly 
observed between several choroidal thicknesses, age 
(P<0.020) and ocular AXL (P<0.030). On the contrary, a 
significant positive correlation was found between all 
choroidal thicknesses, HbA1c (P<0.035) and albuminuria 
(P<0.040). 
● CONCLUSION: Choroidal thickness can represent an 
additional tool to help clinicians predicting the renal status 
in ocular treatment-naïve diabetic patients.
● KEYWORDS: choroidal thickness; renal function; swept-
source optical coherence tomography; spectral-domain optical 
coherence tomography; diabetes mellitus
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INTRODUCTION
D iabetes mellitus (DM) is a complex progressive disease associated with multiple physiopathological alterations 
that ultimately cause macro- and microvascular complications 
(nephropathy, retinopathy and/or neuropathy)[1].  The prevalence 
of DM has increased in the last decades and has become a 
major clinical and social concern due to its economic burden 
and associated premature mortality. The overall prevalence of 
DM in Spain (types 1 and 2) in subjects >18 years of age is 
13.8%[2], with a remarkably higher prevalence of DM2, which 
accounts for 90% of DM[3].
DM is the main cause of chronic kidney disease (CKD) in 
developed countries[4]. Diabetic patients are three times more 
likely to develop CKD as compared to non-diabetic subjects. 
The natural course of diabetic nephropathy is characterized by 
changes in urinary excretion of albumin, which are divided into 
three phases: normoalbuminuria, microalbuminuria (MA) and 
proteinuria. The proportion of patients with DM2 who develop 
MA at 10y after diagnosis is approximately 25%. The presence 
of MA is known to increase overall mortality, cardiovascular 
morbimortality, the risk for end-stage renal disease (ESRD) 
and the risk for proliferative diabetic retinopathy. However, the 
correlation of MA with early-stage retinopathy is still unclear[5]. 
There is scant literature assessing the relationship between 
retinal structural changes and renal function in subjects with 
DM. It has long been known that diabetic patients with chronic 
retinopathy and nephropathy experience a thickening of 
glomerular and retinal capillary vessels. This is suggestive that 
DM and renal function may share microvascular pathogenic 
mechanisms related to abnormalities in glucose metabolism, 
inflammatory alterations and endothelial dysfunction[6]. A recent 
study revealed that renal dysfunction might be associated with a 
reduced retinal blood flow in early-stage diabetic retinopathy[7].
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The development of swept-source optical coherence tomography 
(SS-OCT) has allowed to detect diagnostic alterations related 
to chorioretinopathies including diabetic chorioretinopathy. 
The use of a longer laser wavelength (1050 nm) in SS-OCT 
scans has helped minimize dispersion caused by the retinal 
pigment epithelium. Thus, SS-OCT provides a clear picture of 
the outer retinal layers, primarily the choroid. Ultrahigh speed 
imaging (100 000 A-scans/s) provides faster and more detailed 
B-scans (maximum resolution: 1 µm), as compared to spectral-
domain optical coherence tomography (SD-OCT).
Previous studies based on electronic microscopy have 
already recorded the presence of vascular abnormalities in 
diabetic choriodopathy similar to those found in retinopathy 
(microaneurysms, tortuous vessels, non-perfused quadrants, 
etc.)[8]. New high-resolution devices will help better understand 
the choroid, the vascular layer of the eye which provides 
oxygen and nourishment to the outer layers of the retina. 
Choroidal alterations may precede findings related to the 
presence of retinopathy in fundoscopy.
The primary goal of this study was to investigate the 
relationship between choroidal thickness in diabetic patients 
and their demographic, ocular and lab-test characteristics, with 
special focus on renal function parameters.
SUBJECTS AND METHODS
Ethical Approval  This study protocol has been approved 
by the Ethics Committee of the Virgen Macarena and Virgen 
del Rocío University Hospitals and adheres to the tenets of 
the Declaration of Helsinki. All recruited patients provided 
informed consent ahead of participation.
A cross-sectional study of 42 eyes of 21 diabetic patients 
referred from the Department of Endocrinology to the 
Department of Ophthalmology for regular fundus examination 
during the first semester of 2016. 
Inclusion criteria were: 1) diabetic patients without any previous 
treatment based on argon-laser retinal photocoagulation, 
intravitreal injection of antiangiogenic drugs or pars plana 
vitrectomy; 2) myopic or hypermetropic refractive error <6 
diopters; 3) ocular axial length (AXL) between 21 and 26 mm; 
4) transparent ocular media to obtain acceptable quality 
scans; 5) normal eye fixation; 6) absence of chorioretinal 
pathology other than diabetic retinopathy (age-related macular 
degeneration, retinal vein occlusion, etc.).
Based on these criteria, only 1 of the 42 eyes selected was 
excluded, as the patient had a severe amblyopia in her left eye 
that hindered eye fixation during scanning. The right eye did 
meet inclusion criteria.
Study variables included: 1) demographic variables: age; sex; 
type and course of diabetes. 2) Ocular parameters: severity 
of diabetic retinopathy based on 7-standard field fundus 
photography performed using Visucam 500 (Carl Zeiss 
Meditec AG, Jena, Germany); retinal thickness (Figure 1A) 
at the central macular region (CMT), as well as choroidal 
thickness (Figure 1B) at the central (C-CT), inner nasal (IN-
CT), inner superior (IS-CT), inner temporal (IT-CT) and 
inner inferior (II-CT) quadrants (expressed in μm), using 
automatically generated maps based on the standard Early 
Treatment Diabetic Retinopathy Study (ETDRS) grid of the 
SS-OCT Triton (Topcon Corporation Ltd., Tokyo, Japan); 
presence of cystic macular edema (CME) in the horizontal 
7×7-mm foveal tomography scan (Figure 1); and ocular AXL 
(expressed in mm) measured using the ophthalmic ultrasound 
system OcuScan RxP (Alcon Laboratories Inc., Fort Worth, 
Texas, USA). 3) Lab-test parameters (data were collected from 
recent routine endocrinology consultations within a maximum 
interval of 1mo): glycated hemoglobin HbA1c (expressed as 
percentages); albuminuria (mg/L); albumin/creatinine ratio 
Figure 1 SS-OCT scans showing retinal (A) and choroidal (B) thickness maps generated by automatic layer segmentation  Intraretinal 
cysts can be seen in the macular region.
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(ACR) in urine (mg/g); and glomerular filtration rate 
(GFR) estimated by the formulas CKD-EPI and MDRD-4 
(mL/min/1.73 m2).
Statistical analysis was performed using IBM SPSS version 
23.0 for Windows (SPSS Inc., Chicago, Illinois, USA) and 
Excel 2013 spreadsheets (Microsoft Corporation, Redmond, 
Washington, USA).
Quantitative variables were expressed as means and standard 
deviations, whereas qualitative variables were expressed as 
percentages. Linear associations between quantitative variables 
were determined by Spearman’s rank correlation coefficients. 
The absence of autocorrelation between adjacent observations 
was confirmed by the Durbin-Watson test. Thus, analysis was 
performed in 41 eyes.
For bivariate analysis of normally distributed quantitative 
and qualitative variables (Shapiro-Wilk test), Student’s t-test 
was used to compare two independent samples, and ANOVA 
was used for more than two independent samples. In case of 
abnormal distribution, Mann-Whitney U and Kruskal-Wallis 
non-parametric tests were performed, respectively. A P value 
<0.05 was considered statistically significant.
RESULTS
Descriptive Analysis
Demographic variables  Mean age was 49.76±17.61y (ranging 
from 18 to 74y) and 52.4% of study subjects were male. Most 
patients had type 2 DM (66.7%) and the mean duration of 
disease was 12.14±10.08y.
Ocular variables  The mean ocular AXL was 23.14±1.14 mm. 
The 51.2% did not have retinopathy, whereas 34.2% had mild 
non-proliferative diabetic retinopathy (NPDR) and 14.6% had 
moderate NPDR. SS-OCT revealed the presence of CME in 
five eyes (12.2%). The mean CMT was 246.4±30.39 µm. At 
choroidal level, the mean C-CT was 262.90±77.25 µm, while 
the mean thickness of inner paracentral regions was distributed 
in ascending order as follows: IN-CT (245.56±77.95 µm), 
II-CT (255.00±80.99 µm), IT-CT (256.40±74.96 µm), and IS-
CT (273.00±76.15 µm).
Lab-test parameters  The mean HbA1c was 8.19±1.37%. 
As to renal function parameters, the mean albuminuria was 
36.85±67.76 mg/L, the mean ACR was 37.92±74.27 mg/g and 
the mean GFR as calculated by the CKD-EPI and MDRD-4 
formulas was 98.43±22.33 and 101.90±28.75 mL/min/1.73 m2, 
respectively.
Bivariate Analysis of Choroidal Thickness
Demographic variables  A statistically significant negative 
correlation was observed between age and C-CT (P=0.010), 
IS-CT (P=0.016), IT-CT (P=0.007), and II-CT (P=0.006). In 
contrast, years of evolution of diabetes were not observed to 
be significantly correlated to choroidal thickness. Statistically 
significant differences were also observed in CMT (P=0.0005) 
and IN-CT (P=0.048) between men and women, as well as in 
C-CT (P=0.040) and IT-CT (P=0.025) by type of diabetes.
Ocular variables  Ocular AXL was found to be negatively 
correlated to C-CT (P=0.029), IN-CT (P=0.006), and II-CT 
(P=0.012). There were no significant differences between 
the right and the left eye in any choroidal thickness. In 
relation to the grade of diabetic retinopathy, differences were 
only observed in IT-CT (P=0.016). Nevertheless, a non-
significant inverse trend was observed in choroidal thickness 
as the severity of NPDR increased. Patients with CME 
showed a statistically significant increase of CMT (P=0.048) 
accompanied by a general non-significant choroidal thinning.
Quantitative lab-test parameters  Among renal function 
parameters, albuminuria was found to have a statistically 
significant positive correlation with chorioretinal thicknesses, 
occurring the same with glycosylated hemoglobin (Table 1).
DISCUSSION
The distribution of choroidal thicknesses in diabetic patients 
has been proven to be similar to that in non-diabetic patients, 
with the superior quadrant thicker than the inferior, and the 
temporal thicker than the nasal quadrant[9]. Likewise, evidence 
has been obtained that HbA1c, but not blood glucose, is 
directly correlated to choroidal thickness[10]. The results from 
our study coincide with these findings.
Comparative studies of choroidal thickness in diabetic patients 
with retinopathy and/or macular edema reveal a tendency 
to thinning[11], although statistically significant results have 
not been obtained in our investigation. In contrast, some 
studies have reported choroidal thickening in diabetic patients 
without retinopathy[12], or independently of disease stage[13]. 
Other studies have uncovered choroidal thinning in diabetic 
patients treated with argon laser or intravitreal injections of 
antiangiogenic drugs, as they reduce vascular permeability[14]. 
In addition, the thinning of the choroid with age and ocular 
AXL, reported in previous publications[11], is supported by the 
results of our study. The advantage of the SS-OCT device used 
for chorioretinal measurements is that it provides automatically 
generated maps based on the standard ETDRS grid, versus 
manual measurements with substantial intra- and inter-
observer differences of up to 32 µm[15]. Circadian variations in 
choroidal thickness should be taken into account as well. It has 
been observed that choroidal thickness progressively decreases 
between 9 a.m. and 5 p.m., with diurnal amplitudes of 
up to 67 µm[16-17]. In our study, measurements were always 
performed at the same hour interval, i.e. from 10 a.m. to 1 p.m., 
by the same ophthalmologist who manually re-adjusted the 
segmentation slabs in the infrequent case the automated 
process produced errors, trying to minimize bias.
Regarding the renal function, considering the growing 
incidence of DM and diabetic nephropathy worldwide, early 
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detection of the disease is crucial, as it allows to administer 
timely therapies and prevent progression to ESRD. Urine 
markers, especially MA, play a major role in early detection. 
MA is also a marker of generalized endothelial dysfunction 
associated with DM, thus linking renal impairment to 
cardiovascular and brain compromise. It has been demonstrated 
that MA is not only a marker of glomerular injury, but also of 
renal tubular lesions. Ongoing studies are analyzing other urine 
markers (transferrin, ceruloplasmin), which could precede the 
establishment of MA in some patients[18].
The reduction of GFR generally occurs secondary to MA, although 
it may also occur in patients with normoalbuminuria[19]. For 
this reason, we quantified albuminuria levels in all patients, 
not only in patients with MA (30-300 mg/L). MA has a 
variable course. It can return to normal levels, progress to 
macroalbuminuria, or remain stable without any changes. Even 
so, MA has been proven to be a predictor of cardiovascular 
risk and ESRD in diabetic patients[20].
A recent paper assessed the relationship between MA and 
choroidal thickness[21]. The authors documented a significant 
thinning of the choroid in the group of patients with DM2 
and MA, especially at the subfoveal and temporal to the 
fovea regions. In that study, where SD-OCT scanning was 
used, choroidal thicknesses were measured manually by an 
experienced operator at several points of a horizontal section 
through the fovea. Additionally, confounding factors such 
as ocular AXL, refractive errors or capture time were not 
considered, at least initially, as a replica study was performed 
later[22]. In contrast, our study included patients with DM1 
and 2, with non-excluding refractory defects and ocular 
AXL. Albuminuria levels were correlated with choroidal 
thicknesses automatically mapped on ETDRS grids by SS-
OCT. Scans were performed within the same hour range. We 
found a statistically significant positive correlation between 
albuminuria levels and all choroidal thicknesses measured. 
These results are in agreement with those of previous studies 
reporting a thickening of the choroid in diabetic patients 
without retinopathy[12], or independently of disease stage[13], 
probably associated with a vascular hyperpermeability status.
Another study performed in 2013 documented a thinning of the 
choroid following hemodialysis in non-diabetic patients[23]. The 
authors theorized that ultrafiltration may induce hypovolemia 
and increase plasma oncotic pressure, which would reduce 
intraocular pressure and choroidal thickness. Therefore, the 
opposite would occur when albuminuria increases. Subsequent 
studies demonstrated greater reduction in choroidal thickness 
after hemodialysis in diabetic patients with ESRD[24-25]. The 
authors speculated that it might be due to diabetes-related 
vascular changes in the choroid, including alterations in its 
autonomic regulation.
In conclusion, choroidal thickness could represent an additional 
tool to help clinicians predicting the renal status in ocular 
treatment-naïve diabetic patients. Nevertheless, the preliminary 
retrospective cross-sectional design without a control group 
and the limited sample size of this study require that larger, 
prospective, long-term studies are conducted to confirm the 
results obtained and elucidate the role of choroidopathy in the 
prognosis of diabetic retinopathy.
Table 1 Correlations between chorioretinal thicknesses, renal function parameters and HbA1c
Parameters A ACR GFR CKD-EPI GFR MDRD-4 HbA1c
CMT
Correlation coefficient 0.428 0.226 -0.139 -0.148 0.336
P 0.005 0.156 0.385 0.357 0.031
C-CT
Correlation coefficient 0.394 0.181 0.104 0.018 0.412
P 0.011 0.258 0.517 0.912 0.007
IN-CT
Correlation coefficient 0.324 0.145 0.091 0.031 0.374
P 0.039 0.364 0.570 0.846 0.016
IS-CT
Correlation coefficient 0.389 0.231 0.024 -0.092 0.432
P 0.012 0.147 0.884 0.567 0.005
IT-CT
Correlation coefficient 0.359 0.145 0.131 0.013 0.441
P 0.021 0.365 0.415 0.937 0.004
II-CT
Correlation coefficient 0.351 0.114 0.276 0.194 0.359
P 0.025 0.477 0.081 0.224 0.021
A: Albuminuria; ACR: Albumin/creatinine ratio in urine; GFR CKD-EPI: Glomerular filtration rate based on the CKD-EPI formula; GFR 
MDRD-4: Glomerular filtration rate based on the MDRD-4 formula; HbA1c: Glycated hemoglobin A1c; CMT: Central macular thickness; CT: 
Choroidal thickness; C-CT: Central CT; IN-CT: Inner nasal CT; IS-CT: Inner superior CT; IT-CT: Inner temporal CT; II-CT: Inner inferior CT.
Renal function and choroidal thickness
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